Search for: "Watson Pharma"
Results 21 - 40
of 184
Sorted by Relevance
|
Sort by Date
13 Jan 2013, 9:06 pm
• Defendants: Apotex Inc.; Apotex Corp.; Sandoz, Inc.; Hi-Tech Pharmacal Co., Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
24 Mar 2013, 8:01 pm
– Florida; Watson Pharma, Inc.; Actavis, Inc. [read post]
5 Apr 2015, 9:59 pm
Watson Laboratories Inc. et al. 1:15-cv-00289; filed April 1, 2015 in the District Court of Delaware • Plaintiffs: Gilead Sciences Inc.; Royalty Pharma Collection Trust • Defendants: Watson Laboratories Inc.; Actavis Inc.; Actavis plc Infringement of U.S. [read post]
13 Sep 2015, 9:21 pm
• Defendants: Watson Laboratories, Inc.; Actavis, Inc.; Actavis Pharma, Inc. [read post]
9 Dec 2007, 9:33 pm
On Tuesday, Watson announced that it settled litigation with Biovail over its generic version of Cardizem LA. [read post]
9 Mar 2008, 7:26 pm
Watson Laboratories, Inc. et al. 3:08-cv-00116; filed March 6, 2008 in the District Court of... [read post]
26 Aug 2012, 9:00 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
2 Mar 2014, 8:47 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
10 Jun 2014, 5:25 pm
., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
16 Jun 2020, 9:59 pm
Watson Laboratories Inc. and Galderma Laboratories, L.P. v. [read post]
9 Mar 2014, 9:31 pm
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
31 Aug 2014, 9:05 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
5 Apr 2011, 9:24 pm
By James DeGiulio -- Cephalon's Fentora Patent Found Valid, Infringed by Watson Cephalon enjoyed a needed victory in its patent dispute with Watson over Fentora after one of the patents at issue in the case was upheld and Watson's proposed generic of Fentora was found to infringe that patent. [read post]
9 Aug 2009, 10:02 pm
The recalled patches are from Lot Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. [read post]
15 Mar 2011, 9:56 pm
In September 2009, Cephalon brought another suit against Watson, alleging... [read post]
26 May 2012, 8:41 pm
Back in March we wrote about a number of ongoing cases between original manufacturer AstraZeneca AB, and generic pharmaceutical companies Apotex Pty Ltd, Watson Pharma Pty Ltd and Ascent Pharma Pty Ltd, over cholesterol drug rosuvastatin, marketed in Australian by AstraZeneca as CRESTOR. [read post]
28 Feb 2010, 9:47 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
11 Mar 2012, 3:32 pm
Meanwhile, two other manufacturers – Watson Pharma Pty Ltd and Ascent Pharma Pty Ltd – have been gearing up to follow Apotex’s lead in launching their own generic rosuvastatin products (rosuvastatin is the active ingredient in CRESTOR), and also faced applications by AstraZeneca for preliminary injunctions. [read post]
28 Mar 2008, 8:59 pm
Last week, FDA Law Blog reported on a recent FDA determination that Watson Labs forfeited its 180-day exclusivity on generic Camptosar (irinotecan HCl) because it failed to obtain tentative approval of its ANDA within 30 months of filing, as required by the MMA. [read post]
9 Apr 2009, 9:14 pm
Before the trial commenced, the plaintiffs had offered Watson a covenant not to sue for Watson's practice of another patent at issue in the case, U.S. [read post]
